Splenic rupture associated with primary CMV infection, AMSAN, and IVIG
de Havenon A, Davis G, Hoesch R. Splenic rupture associated with primary CMV infection, AMSAN, and IVIG. Journal Of Neuroimmunology 2014, 272: 103-105. PMID: 24856574, DOI: 10.1016/j.jneuroim.2014.05.004.Peer-Reviewed Original ResearchConceptsPrimary cytomegalovirus infectionGuillain-Barré syndromeIntravenous immunoglobulinSplenic ruptureCytomegalovirus infectionPrimary CMV infectionTwo-hit scenarioSequestration of erythrocytesExtravascular hemolytic anemiaRisk of ruptureCMV infectionRare complicationHemolytic anemiaImmunoglobulinInfectionSyndromeRuptureTreatmentRiskIVIGAMSANComplicationsPatientsAnemiaSpleenGenetic alterations in chondrosarcomas – keys to targeted therapies?
Samuel AM, Costa J, Lindskog DM. Genetic alterations in chondrosarcomas – keys to targeted therapies? Cellular Oncology 2014, 37: 95-105. PMID: 24458248, DOI: 10.1007/s13402-014-0166-8.Peer-Reviewed Original ResearchConceptsBenign cartilaginous lesionsCartilaginous lesionsMalignant transformationIhh/PTHrPTwo-hit scenarioPrimary bone tumorsGenetic alterationsDruggable molecular targetsKey genetic alterationsHuman tumor typesResultsCurrent dataBone tumorsMalignant tumorsSarcoma typesMalignant chondrosarcomasKey molecular changesNormal cell cycle controlTumor typesMalignant cellsChondrosarcoma developmentLesionsMolecular targetsTumorsEarly-stage eventsDifferentiation of chondrocytes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply